Kolkata: The Guru Nanak Institute of Pharmaceutical Science and Technology (GNIPST), an educational initiative of the JIS Group, organised a two-day international conference titled “Frontiers in Medical, Pharmaceutical and Allied Sciences: Translating Innovation into Impact.” The conference brought together global experts, academicians, researchers, healthcare professionals, industry leaders, and policymakers to explore emerging trends and innovations shaping the future of healthcare.
The event served as a global knowledge-sharing platform focused on bridging the gap between laboratory discoveries and real-world healthcare solutions. Discussions centred on cutting-edge developments in drug discovery, biotechnology, precision medicine, regulatory science and healthcare technology, with a strong emphasis on translational research and practical implementation.
Delivering the keynote plenary address, David L. Whitford, Vice Chancellor and CEO of the University of Cyberjaya, Malaysia, highlighted the importance of innovation ecosystems and international collaboration in translating scientific discoveries into impactful healthcare solutions. The conference was also graced by Achintya Saha, former Vice-Chancellor of Murshidabad University, who emphasised the role of academic research in driving healthcare advancements.
Technical sessions featured several eminent speakers from academia and regulatory bodies. Among them were W. W. C. Dissanayake, Pharmaceutical Assessor at the National Medicines Regulatory Authority, Sri Lanka, and J. A. C. Perera, Pharmaceutical Assessor at NMRA. Other distinguished speakers included Ashok Kumar Balaraman, Director of Research Management at the University of Cyberjaya; Shyamalendu Mukhopadhyay, former Director of the Directorate of ISM Drugs Control and State Medicinal Plants Board; Arup Mukherjee from Maulana Abul Kalam Azad University of Technology; Biswajit Mukherjee from Jadavpur University; and Subhamoy Ghosh of D. N. De Homoeopathic Medical College & Hospital.
The conference covered a wide range of themes including translational medicine, biopharmaceuticals, precision medicine, natural product research, regulatory science, artificial intelligence in healthcare, advanced diagnostics, public health innovations, and data-driven healthcare systems.
Speaking on the occasion, Taranjit Singh, Managing Director of the JIS Group, said the conference reflects the group’s strong commitment to advancing research, encouraging global collaboration, and developing innovative solutions that can significantly enhance healthcare delivery and public well-being.
The event highlighted Kolkata’s growing role as a centre for international academic collaboration in medical and pharmaceutical sciences, reinforcing the importance of multidisciplinary research in addressing global healthcare challenges.
